Atossa Therapeutics, Inc.
Biotechnology ResearchUnited States51-200 Employees
Atossa Genetics Inc. (NASDAQ: ATOS) is developing locally-administered pharmaceuticals for pre-cancerous breast conditions and early stage breast cancer.
Insights
Expansion Potential Atossa Therapeutics has demonstrated growth through strategic board additions and leadership hires, indicating an active expansion phase that may benefit from targeted sales efforts in partnership development and new market entry.
Innovative Pipeline Focusing on locally-administered treatments for pre-cancerous breast conditions and early-stage breast cancer positions the company uniquely within the biotech sector, presenting opportunities to collaborate on innovative healthcare solutions.
Financial Capacity With revenue between $10M and $25M and overall funding of $25M, Atossa has sufficient resources for research collaborations, clinical trials, or expanding their product reach—making them a promising partner for biotech product distribution.
Market Focus Specializing in breast health and early intervention therapeutics offers potential sales avenues with hospitals, clinics, and specialty healthcare providers focusing on oncology and preventative care.
Technical Integration The company's adoption of various web and data visualization technologies suggests an emphasis on digital engagement and data-driven decision-making, which could facilitate collaborations in health tech, data analytics, or digital health solutions.
Similar companies to Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Tech Stack
Atossa Therapeutics, Inc. uses 8 technology products and services including Font Awesome, yepnope.js, Handlebars, and more. Explore Atossa Therapeutics, Inc.'s tech stack below.
- Font AwesomeFont Scripts
- yepnope.jsJavascript Frameworks
- HandlebarsJavascript Frameworks
- amChartsJavascript Graphics
- jQueryJavascript Libraries
- Yoast SEOSearch Engines
- BootstrapUI Frameworks
- GoDaddyWeb Hosting
Media & News
Atossa Therapeutics, Inc.'s Email Address Formats
Atossa Therapeutics, Inc. uses at least 1 format(s):
| Atossa Therapeutics, Inc. Email Formats | Percentage |
| First.Last@atossagenetics.com | 46% |
| Last@atossagenetics.com | 5% |
| First@atossagenetics.com | 3% |
| First.Last@atossagenetics.com | 46% |
Frequently Asked Questions
Where is Atossa Therapeutics, Inc.'s headquarters located?
Atossa Therapeutics, Inc.'s main headquarters is located at 1616 Eastlake Ave E, Suite 201, Seattle, WA 98102, US. The company has employees across 2 continents, including North AmericaAsia. What is Atossa Therapeutics, Inc.'s phone number?
You can contact Atossa Therapeutics, Inc.'s main corporate office by phone at +1-206-588-****
What is Atossa Therapeutics, Inc.'s stock symbol?
Atossa Therapeutics, Inc. is a publicly traded company; the company's stock symbol is ATOS. What is Atossa Therapeutics, Inc.'s official website and social media links?
Atossa Therapeutics, Inc.'s official website is atossagenetics.com and has social profiles on LinkedInCrunchbase.What is Atossa Therapeutics, Inc.'s SIC code NAICS code?
Atossa Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Atossa Therapeutics, Inc. have currently?
As of October 2025, Atossa Therapeutics, Inc. has approximately 51 employees across 2 continents, including North AmericaAsia. Key team members include Vice President, Investor And Public Relations: M. P.Senior Medical Director Clinical Development: A. M.Director Clinical Development: H. S.. Explore Atossa Therapeutics, Inc.'s employee directory with LeadIQ.What industry does Atossa Therapeutics, Inc. belong to?
Atossa Therapeutics, Inc. operates in the Biotechnology Research industry. What technology does Atossa Therapeutics, Inc. use?
Atossa Therapeutics, Inc.'s tech stack includes Font Awesomeyepnope.jsHandlebarsamChartsjQueryYoast SEOBootstrapGoDaddy. What is Atossa Therapeutics, Inc.'s email format?
Atossa Therapeutics, Inc.'s email format typically follows the pattern of First.Last@atossagenetics.com. Find more Atossa Therapeutics, Inc. email formats with LeadIQ. How much funding has Atossa Therapeutics, Inc. raised to date?
As of October 2025, Atossa Therapeutics, Inc. has raised $25M in funding. The last funding round occurred on Jan 01, 2021 for $25M.When was Atossa Therapeutics, Inc. founded?
Atossa Therapeutics, Inc. was founded in 2009.
Company Overview
- Headquarters
- 1616 Eastlake Ave E, Suite 201, Seattle, WA 98102, US
- Phone number
- +1-206-588-****
- Website
- atossagenetics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- ATOS
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2009
- Employees
- 51-200
Funding & Financials
- $25M
Atossa Therapeutics, Inc. has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Jan 01, 2021 in the amount of $25M.
- $10M$25M
Atossa Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $25M
Atossa Therapeutics, Inc. has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Jan 01, 2021 in the amount of $25M.
- $10M$25M
Atossa Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M
Company Leadership
M. P.Vice President, Investor And Public Relations- A. M.Senior Medical Director Clinical Development
- H. S.Director Clinical Development
- H. E.Associate Director, Clinical Operations
- S. H.Science Program Manager At Atossa Therapeutics
Employee Directory
- N. M.Quality And Regulatory Affairs Sr Specialist
J. F.Member Board Of Directors- G. W.Member Of Board Of Directors
T. H.Registered Dietitian- E. H.Vice President, Regulatory Affairs, Quality And Clinical
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
